Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Protease Inhibitors”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00801255
What this trial is testing

Combination Treatment With an HCV Polymerase Inhibitor (RO5024048) and an HCV Protease Inhibitor (RO5190591/Danoprevir) in Genotype 1 Chronic Hepatitis C Patients

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 88
Not applicableStudy completedNCT00483392
What this trial is testing

Treatment of Hyperglycaemia and Insulin Resistance in HIV Infected Patients

Who this might be right for
Insulin Resistance
University Medical Centre Ljubljana
Large-scale testing (Phase 3)Ended earlyNCT01923311
What this trial is testing

Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric Participants

Who this might be right for
Acquired Immune Deficiency Syndrome (AIDS)HIV Infections
Gilead Sciences 31
Testing effectiveness (Phase 2)Study completedNCT02870348
What this trial is testing

Long-term Safety of Alpha1-Proteinase Inhibitor (Human) in Japanese Subjects With Alpha1 Antitrypsin Deficiency (GTI1401-OLE)

Who this might be right for
Alpha1-Antitrypsin Deficiency
Grifols Therapeutics LLC 4
Post-approval studies (Phase 4)Study completedNCT01772940
What this trial is testing

Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited Setting

Who this might be right for
HIV-1 Infection
Centre Hospitalier Universitaire Saint Pierre 425
Large-scale testing (Phase 3)Looking for participantsNCT06679140
What this trial is testing

Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

Who this might be right for
COVID-19 SARS-CoV-2 Infection
Pfizer 2,330
Testing effectiveness (Phase 2)Study completedNCT06928051
What this trial is testing

S-892216 in Participants With COVID-19

Who this might be right for
COVID-19
Shionogi 282
Early research (Phase 1)Study completedNCT00002351
What this trial is testing

L-735,524 in HIV-Positive Children and Adolescents

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 12
Large-scale testing (Phase 3)Study completedNCT01146873
What this trial is testing

Treatment Options for Protease Inhibitor-exposed Children

Who this might be right for
HIV/AIDSHIV Infections
Columbia University 300
Large-scale testing (Phase 3)Study completedNCT00381303
What this trial is testing

GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men.

Who this might be right for
HIVInfectious
Tibotec, Inc 429
Not applicableStudy completedNCT00202241
What this trial is testing

The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDS

Who this might be right for
HIVAIDSLipodystrophy+1 more
Queen's University 30
Not applicableStudy completedNCT00432783
What this trial is testing

A Comparison of Adherence Rates to Ritonavir and Its Accompanying Protease Inhibitor

Who this might be right for
HIV Infections
Montefiore Medical Center 45
Testing effectiveness (Phase 2)Study completedNCT00225303
What this trial is testing

TMC125-C227: A Phase II Randomized, Active-Controlled, Open Label Trial to Investigate the Efficacy and Tolerability of TMC125 in HIV-1 Infected Subjects, Who Are PI-Naive and With Documented Genotypic Evidence of NNRTI Resistance From Previous NNRTI Use

Who this might be right for
HIV Infection
Tibotec Pharmaceuticals, Ireland 116
Large-scale testing (Phase 3)Study completedNCT00094523
What this trial is testing

Fosamprenavir Versus Other Protease Inhibitors

Who this might be right for
Infection, Human Immunodeficiency Virus I
ViiV Healthcare 314
Post-approval studies (Phase 4)Ended earlyNCT00122668
What this trial is testing

Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients

Who this might be right for
HIV InfectionsHIV-Associated Lipodystrophy Syndrome
French National Agency for Research on AIDS and Viral Hepatitis 112
Large-scale testing (Phase 3)Study completedNCT00002406
What this trial is testing

A Comparison of Two Dose Levels of Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected Patients

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 350
Large-scale testing (Phase 3)Study completedNCT00002193
What this trial is testing

Safety and Effectiveness of Giving Two Nucleoside Reverse Transcriptase Inhibitors Alone or in Combination With 141W94 to HIV-Infected Children Who Have Never Received Protease Inhibitors

Who this might be right for
HIV Infections
Glaxo Wellcome 210
Early research (Phase 1)Study completedNCT00000901
What this trial is testing

Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableStudy completedNCT00002155
What this trial is testing

A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TC

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 600
Not applicableStudy completedNCT00001885
What this trial is testing

Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis

Who this might be right for
HealthyPulmonary FibrosisRheumatoid Arthritis
National Heart, Lung, and Blood Institute (NHLBI) 400
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation